摘要
新冠肺炎是一种新兴的疾病,是对全球社会的主要威胁。这种疾病的主要挑战是缺乏适当的或经过证实的药物治疗。用于治疗这种疾病的药物仅用于对症治疗。对其他冠状病毒,如SARS和MERS的研究表明,槲皮素有足够的潜力治疗covid-19。先前的研究表明,槲皮素通过阻断ACE2受体,以及降低SARS和MERS患者的白细胞介素-6水平,来减少病毒进入细胞的途径。因此,本综述的目的是从分子的角度仔细研究槲皮素作为一种治疗covid-19的药物的潜力。
关键词: 槲皮素、治疗性、covid-19、ACE2、SARS、MERS。
Current Molecular Medicine
Title:Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview
Volume: 21 Issue: 5
关键词: 槲皮素、治疗性、covid-19、ACE2、SARS、MERS。
摘要: COVID-19 is an emerging disease that is a major threat to the global community. The main challenge in this disease is the lack of proper or proven medication. The drugs used to treat this disease are only for symptomatic treatment. Studies of other coronaviruses, such as SARS and MERS, suggest that quercetin has sufficient potential to treat COVID-19. Previous studies have shown that quercetin reduces the entry of the virus into the cell by blocking the ACE2 receptor, as well as reducing the level of interleukin-6 in SARS and MERS patients. Therefore, the aim of this review was to scrutinize the potential of quercetin as a drug in the treatment of COVID-19 from a molecular perspective.
Export Options
About this article
Cite this article as:
Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview, Current Molecular Medicine 2021; 21 (5) . https://dx.doi.org/10.2174/1566524020999200918150630
DOI https://dx.doi.org/10.2174/1566524020999200918150630 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Two-step Similarity-based Method for Prediction of Drug’s Target Group
Protein & Peptide Letters Andrographolide Mitigates Unfolded Protein Response Pathway and Apoptosis Involved in Chikungunya Virus Infection
Combinatorial Chemistry & High Throughput Screening Preface
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Interplay of Immunity and Vitamin D: Interactions and Implications with Current IBD Therapy
Current Medicinal Chemistry High-Sensitivity C-Reactive Protein and Lipoprotein-Associated Phospholipase A2 in Predicting Recurrence and Severity of Stenosis in Symptomatic Intracranial Atherosclerotic Disease
Current Proteomics Changes in Markers of Bone Metabolism Following Surgery
Recent Patents on Biomarkers Monoclonal Antibodies in the Treatment of Leukemia
Current Molecular Medicine The Human Indoleamine 2,3-Dioxygenase Gene and Related Human Genes
Current Drug Metabolism Recent Strategies Combining Biomaterials and Stem Cells for Bone, Liver and Skin Regeneration
Current Stem Cell Research & Therapy Natural and Induced Antibody Polyreactivity
Anti-Cancer Agents in Medicinal Chemistry Malaria Stage-Specific Vaccine Candidates
Current Pharmaceutical Design PC9, A New Actor in Autosomal Dominant Hypercholesterolemia
Current Genomics Synthetic Lethal Interactions in Cancer Therapy
Current Cancer Drug Targets E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets
Current Cancer Drug Targets Recently Patented Viral Nucleotide Sequences and Generation of Virus-Derived Vaccines
Recent Patents on Anti-Infective Drug Discovery New Perspectives in the Treatment of Melanoma: Anti-Angiogenic and Anti-Lymphangiogenic Strategies
Recent Patents on Anti-Cancer Drug Discovery Advances and Implications in Nanotechnology for Lung Cancer Management
Current Drug Metabolism Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis via Osteocyte
Current Drug Targets The Effect of Sodium Metabisulphite on Apoptosis in the Experimental Model of Parkinson’s Disease
Current Nutrition & Food Science Sofosbuvir: Really Meets the Unmet Needs for Hepatitis C Treatment?
Infectious Disorders - Drug Targets